Abstract
Tick-borne encephalitis virus (TBEV) causes severe encephalitis in humans. It is endemic in one area of Japan; however no commercial vaccine is available in that country. In this Japan-based study, the efficacy of subviral particles (SPs) of TBEV administered by needle-free injector was evaluated as a vaccine candidate. Inoculation with SP-encoding DNA by needle-free injector induced neutralizing antibodies more efficiently than when administered by needle and syringe, and mice vaccinated with one dose by needle-free injector survived challenge with a lethal dose of TBEV. These results suggest that SP vaccines delivered by needle-free injector can protect against TBEV infection.
© 2011 The Societies and Blackwell Publishing Asia Pty Ltd.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Neutralizing / biosynthesis
-
Antibodies, Viral / biosynthesis
-
Antibodies, Viral / blood*
-
DNA, Viral / genetics
-
DNA, Viral / immunology
-
Encephalitis Viruses, Tick-Borne / genetics
-
Encephalitis Viruses, Tick-Borne / immunology*
-
Encephalitis, Tick-Borne / immunology
-
Encephalitis, Tick-Borne / prevention & control*
-
Encephalitis, Tick-Borne / virology
-
Humans
-
Injections, Jet
-
Japan
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Vaccination
-
Vaccines, DNA / administration & dosage*
-
Vaccines, DNA / immunology
-
Vaccines, Synthetic / administration & dosage
-
Vaccines, Synthetic / immunology
-
Viral Proteins / genetics
-
Viral Proteins / immunology
-
Viral Vaccines / administration & dosage*
-
Viral Vaccines / immunology
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
DNA, Viral
-
Vaccines, DNA
-
Vaccines, Synthetic
-
Viral Proteins
-
Viral Vaccines